Chaudhury, S., Reshef, R., Nikiforow, S., George, D. M., Kapoor, N., Kent, M., Krueger, J., Cole, T., Barba, P., Olavarria, E., Valenti, R., Friedetzky, A., Roye, S., Prockop, S. (2025). Subgroup analysis in pediatric patients from the Phase 3 study of tabelecleucel for allogeneic or solid organ transplant recipients with Epstein–Barr virus-driven post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE). Blood. https://doi.org/10.1182/blood-2025-5488